Brief: Silence Therapeutics Says Achieved Another Research Milestone Payment From Mallinckrodt Collaboration For Complement-Mediated Diseases
28/04/2021 12:37
April 28 (Reuters) - Silence Therapeutics PLC SLN.L :
* SILENCE THERAPEUTICS ACHIEVES ANOTHER RESEARCH MILESTONE
PAYMENT
FROM MALLINCKRODT COLLABORATION FOR COMPLEMENT-MEDIATED DISEASES
Source text for Eikon: ID:nGNX3n10cl
Further company coverage: SLN.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Silence Therapeutics
See all newsBrief: Silence Therapeutics Reports Second Quarter 2025 Financial Results And Recent Business Highlights
Brief: Silence Therapeutics files for stock shelf, size not disclosed
Brief: Silence Therapeutics Announces Positive Results From Ongoing Sanreco Phase 1 Study
Brief: Silence Therapeutics Announces Positive Topline 48-Week Data From Phase 2 Study Of Zerlasiran In Patients With Elevated Lipoprotein
Brief: Silence Therapeutics PLC Files For Resale Of Up To 5.71 Million Shares By The Selling Securityholders - SEC Filing